SUPEROXIDE DOES NOT INHIBIT GLYCERYL TRINITRATE-RABBIT AORTIC STRIP-MEDIATED RELAXATION OF RABBIT TAENIA-COLI - EVIDENCE AGAINST A ROLE NITRIC-OXIDE ITSELF AS THE SMOOTH-MUSCLE ACTIVE-DRUG METABOLITE
As. Hussain et al., SUPEROXIDE DOES NOT INHIBIT GLYCERYL TRINITRATE-RABBIT AORTIC STRIP-MEDIATED RELAXATION OF RABBIT TAENIA-COLI - EVIDENCE AGAINST A ROLE NITRIC-OXIDE ITSELF AS THE SMOOTH-MUSCLE ACTIVE-DRUG METABOLITE, Drug metabolism and disposition, 24(7), 1996, pp. 780-785
This study was designed to test the hypothesis that nitric oxide (NO)
is the relaxant metabolite produced by metabolic activation of glycery
l trinitrate (GTN) in rabbit aortic strip (RAS). Superoxide anion, an
inactivator of NO, was included in a two-tissue bioassay in which rabb
it Taenia coli strip (RTCS) relaxed to GTN in the presence of RAS. Sup
eroxide as generated by xanthine (10 mu M)/xanthine oxidase (20 mU/ml)
failed to attenuate relaxations of RTCS to GTN (0.1 nM-10 mu M) and R
AS, compared with the untreated control. In contrast, superoxide atten
uated the relaxation of RTCS to both authentic NO gas and to SIN-1 (0.
1 nM-10 mu M), a known spontaneous releaser of NO; the attenuation of
RTCS relaxation to NO gas was reversed by superoxide dismutase (100 un
its/ml). In addition, another drug that has been reported to scavenge
NO, hydroquinone, did not attenuate the RTCS relaxation to GTN. These
results suggest that biotransformation of GTN in vascular smooth muscl
e that leads to relaxation is caused by a NO-containing species (i.e.
a S-nitrosothiol). Such a molecule would be less susceptible to inacti
vation by superoxide anion and hydroquinone.